Carfilzomib Is Safe in Elderly Patients with Multiple Myeloma but Thrombotic Microangiopathy Is Underestimated in Clinical Practice

被引：0
|
作者：
Terao, Toshiki [1 ]
Tsushima, Takafumi [1 ]
Miura, Daisuke [2 ]
Ikeda, Daisuke [3 ]
Fukumoto, Ami [3 ]
Kuzume, Ayumi [1 ]
Tabata, Rikako [1 ]
Narita, Kentaro [2 ]
Takeuchi, Masami [1 ]
Matsue, Kosei [4 ]
机构：
[1] Kameda Med Ctr, Div Hematol Oncol, Kamogawa, Japan
[2] Kameda Med Ctr, Div Hematol Oncol, Dept Med, Kamogawa, Japan
[3] Kameda Med Ctr, Kamogawashi, Japan
[4] Kameda Gen Hosp, Div Hematol Oncol, Kamogawa, Japan
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-146460
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3798
引用
收藏
页码：3798 / +
页数：5
相关论文
共 50 条
  • [31] Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Elderly Patients with Relapsed Multiple Myeloma: IKEMA Subgroup Analysis
    Facon, Thierry
    Moreau, Philippe
    Martin, Thomas G.
    Spicka, Ivan
    Oriol, Albert
    Koh, Youngil
    Lim, Andrew
    Mikala, Gabor
    Rosinol, Laura
    Yagci, Munci
    Cavo, Michele
    Yong, Kwee
    Risse, Marie-Laure
    Asset, Gaelle
    Schwab, Sandrine
    Martinez, Gracia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S420 - S420
  • [32] Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis
    Facon, Thierry
    Moreau, Philippe
    Martin, Thomas G.
    Spicka, Ivan
    Oriol, Albert
    Koh, Youngil
    Lim, Andrew
    Mikala, Gabor
    Rosinol, Laura
    Yagci, Munci
    Cavo, Michele
    Yong, Kwee
    Risse, Marie-Laure
    Asset, Gaelle
    Schwab, Sandrine
    Martinez, Gracia
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 1020 - 1029
  • [33] Various clinical manifestations in patients with thrombotic microangiopathy
    Chang, JC
    Kathula, SK
    JOURNAL OF INVESTIGATIVE MEDICINE, 2002, 50 (03) : 201 - 206
  • [34] Real-World Practice Patterns with Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma
    Harvey, R. Donald
    Cong, Ze
    Werther, Winifred
    Lethen, Jan L.
    Lonial, Sagar
    BLOOD, 2014, 124 (21)
  • [35] Addiction in the elderly - an underestimated diagnosis in clinical practice?
    Wetterling, T
    Backhaus, J
    Junghanns, K
    NERVENARZT, 2002, 73 (09): : 861 - 866
  • [36] A Phase 2 Study of Prolonged Carfilzomib Therapy in Patients with Multiple Myeloma Previously Enrolled in Carfilzomib Clinical Trials
    Siegel, David S.
    Wang, Michael
    Martin, Thomas G., III
    Infante, Jeffrey R.
    Kaufman, Jonathan L.
    Ranjangam, Kanya
    Huang, Mei
    Bilotti, Elizabeth
    Vij, Ravi
    BLOOD, 2012, 120 (21)
  • [37] From clinical trials to clinical practice: single-agent carfilzomib adverse events and their management in patients with relapsed and/or refractory multiple myeloma
    Siegel, David S.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2013, 4 (06) : 354 - 365
  • [38] Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma
    Dytfeld, Dominik
    Jasielec, Jagoda
    Griffith, Kent A.
    Lebovic, Daniel
    Vesole, David H.
    Jagannath, Sundar
    Al-Zoubi, Ammar
    Anderson, Tara
    Detweiler-Short, Kristen
    Stockerl-Goldstein, Keith
    Ahmed, Asra
    Jobkar, Terri
    Durecki, Diane E.
    McDonnell, Kathryn
    Mietzel, Melissa
    Couriel, Daniel
    Kaminski, Mark
    Vij, Ravi
    Jakubowiak, Andrzej J.
    HAEMATOLOGICA, 2014, 99 (09) : E162 - E164
  • [39] Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis.
    Facon, Thierry
    Moreau, Philippe
    Martin, Thomas G.
    Spicka, Ivan
    Oriol, Albert
    Koh, Youngil
    Lim, Andrew
    Mikala, Gabor
    Rosinol, Laura
    Yagci, Munci
    Cavo, Michele
    Yong, Kwee
    Risse, Marie-Laure
    Asset, Gaelle
    Schwab, Sandrine
    Martinez, Gracia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [40] Echocardiographic Changes of Carfilzomib Therapy in Multiple Myeloma Patients
    Bahaj, Waled
    Albawaliz, Anas
    Begemann, Madeline E.
    Shrestha, Anuj
    Sperry, Brett
    Raza, Shahzad
    BLOOD, 2020, 136
12345